Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non–Small-Cell Lung Cancer and EGFR Mutations?
Male Cancer Research Lung Neoplasms business.industry Adenocarcinoma of Lung Adenocarcinoma Afatinib medicine.disease ErbB Receptors First line treatment Oncology Egfr mutation Antineoplastic Combined Chemotherapy Protocols Quinazolines Cancer research Humans Medicine Female Growth factor receptor inhibitor Non small cell business Lung cancer Tyrosine kinase Epidermal growth factor receptor tyrosine kinase